VP, Strategic Alliances & Healthcare Innovation

Rebecca DeAngel

PhD, MPH

Biotech & Healthcare IP | Invention Matters®

Aligning IP strategy with clinical, biotech, and healthcare innovation.

Back to Team

About

Rebecca DeAngel specializes in biotech intellectual property strategy, medical innovation, and healthcare technology IP, helping organizations translate complex scientific discoveries into defensible and scalable intellectual property.

Her experience spans biotechnology startups, pharmaceutical companies, and precision oncology platforms, where she has contributed to FDA-approved therapeutics, diagnostics, and AI-driven healthcare technologies.

She focuses on aligning patent strategy with clinical development, regulatory pathways, and real-world healthcare applications, ensuring intellectual property supports commercialization, partnerships, and long-term value creation.

Experience

Biotech startups (venture-backed)

Global pharmaceutical organizations

Oncology and diagnostics platforms

Highlights

Expertise in precision oncology and biomarker strategy

Experience supporting FDA-aligned innovation

Focus on clinical and real-world implementation

View Services

Rebecca DeAngel, PhD, MPH

VP, Strategic Alliances & Healthcare Innovation

FOCUS AREAS

Precision oncology

Diagnostics & biomarker strategy

Clinical & regulatory alignment

AI in healthcare

Expertise

10+ years in biotech & pharma

FDA-aligned innovation strategy

Translational research & clinical development

Biotech Healthcare

Align your IP with real-world healthcare impact.

Every engagement matched to the right expertise.

Schedule a Consultation